HEALTH (MSM)

At the Heart of the Matter: Women Need Better Testing Options

We know cardiovascular care has come such a long way in the last decade or so. What many don’t know is that care is based on studies that represent a huge sex disparity. Only 24 percent of participants in all heart-related studies are women. For the last 50 years women’s treatment has largely been based on medical research conducted primarily…

5 Tips for Making New Girlfriends

Have you ever caught yourself thinking that you could really use some new girlfriends?Maybe you’ve moved for a job, outgrown your old circle of friends, recently ended a relationship, or just looked up one day and realized you just didn’t have many.You are not alone sister! Almost every woman I’ve talked to agrees that they’d love more friends,…

Hillary Clinton takes on Jeb Bush on racial equality issues

By Zachary Fagenson FORT LAUDERDALE, Fla. (Reuters) – Hillary Clinton launched a direct assault on Jeb Bush on Friday, questioning his commitment to tackle issues of economic and racial inequality at a convention of a major African American civil rights group. The meeting of the National Urban League was the first same-stage appearance during the 2016 campaign and could be a general election preview for former Secretary of State Clinton,

For seniors, sexual activity is linked to higher quality of life

By Madeline Kennedy (Reuters Health) – Older adults who value sexual activity and engage in it have better social lives and psychological well-being, according to a small study in Scotland Older adults said “they miss and want to engage in sexual behaviors, whether that be a kiss to intercourse,” said study coauthor Taylor-Jane Flynn in an email. “For many, these behaviors remained an important element in their life.” Flynn, a

Vaccine success holds hope for end to deadly scourge of Ebola

By Kate Kelland and Tom Miles LONDON/GENEVA (Reuters) – The world is on the verge of being able to protect humans against Ebola, the World Health Organization said on Friday, as a trial in Guinea found a vaccine to have been 100 percent effective.     Initial results from the trial, which tested Merck and NewLink Genetics’ VSV-ZEBOV vaccine on some 4,000 people who had been in close contact with a